First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
about
Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapyToxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current statusNothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapyTargeted radiotherapy for neuroblastomaClinical radionuclide therapy dosimetry: the quest for the "Holy Gray".The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaThe role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma.Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.Radionuclide therapy of adrenal tumors.Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan.Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
P2860
Q28350866-ACE91FF3-7036-4E0F-9006-2D392811088AQ33409568-A13E2578-F227-4283-B9CA-666C273FE0C2Q33652433-99710B69-E5F6-4E87-99D0-A7A07A3767B6Q34543646-E0B18C6D-E909-4AC5-9697-F2D367722D8DQ35257440-E0783DF6-E9F0-47A4-A133-F5BA5953163FQ35880923-BF64C9B4-0D75-4CFE-B1F3-702EC837E1E4Q36116074-89152B18-A070-4171-810D-2F865ECAEABDQ36353230-6542FCEF-7CCD-43E1-81A7-E2BB5B9F6077Q37078231-9D670308-C434-44E6-9342-8699626D7F05Q37188218-DD48F985-1CA5-4220-9533-78D17D53F0DDQ37334748-272132E9-3801-4412-B374-DBDFC5E59E49Q38020428-BE496EA4-5396-42EA-912D-88FA4DB4BC5DQ41029352-14E6ED7F-2688-4CA9-B57D-82D6B8AFBF8BQ41733479-A16FB3FE-24E8-4FE4-B18A-CCC810F15CD0Q43831004-00D91ABA-250F-469E-9075-E9BB26676969Q43947318-4F62E345-DD04-4F11-967F-A608741DC9B9Q45948464-09237FD7-72CE-4E0E-8BCF-28A88616C761Q51192563-4D175A03-CEF9-4ECD-8B1B-42887669D8A7
P2860
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
First line targeted radiothera ...... advanced stage neuroblastoma.
@ast
First line targeted radiothera ...... advanced stage neuroblastoma.
@en
type
label
First line targeted radiothera ...... advanced stage neuroblastoma.
@ast
First line targeted radiothera ...... advanced stage neuroblastoma.
@en
prefLabel
First line targeted radiothera ...... advanced stage neuroblastoma.
@ast
First line targeted radiothera ...... advanced stage neuroblastoma.
@en
P2093
P1476
First line targeted radiothera ...... advanced stage neuroblastoma.
@en
P2093
De Kraker J
Hoefnagel CA
Valdés Olmos RA
P304
P356
10.1016/0959-8049(95)00063-O
P577
1995-01-01T00:00:00Z